Skip to Main Content
Our Commitment to Diversity

K&L Gates Triage: 340B Update: State Medicaid 340B Billing Requirements

Date: 25 April 2018
Triage

In the midst of the ongoing federal conversation surrounding the 340B Drug Pricing Program, individual states are implementing a number of regulatory efforts related to the 340B Program at an increasingly fast pace. These efforts are largely designed to avoid duplicate discounts, capture Medicaid drug rebates, and reduce reimbursement for 340B drugs. Many states have implemented new requirements at the claims level, though requirements widely vary by state and may vary by setting and whether billed as retail, clinic-administered, or contract pharmacy drugs.

In this episode, Richard Church and Ryan Severson discuss several specific examples of states that are implementing changes to 340B billing procedures and some of the operational and compliance challenges that may arise, particularly for providers enrolled in multiple state Medicaid programs.

About Triage
Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short podcasts.

If you work in the health care industry, you have grown accustomed to frequent changes in laws and regulations. On some days, it may seem like an insurmountable task to keep up with every change, especially as a new presidential administration and new policies take shape.

The K&L Gates Health Care Practice will regularly create Triage podcasts to help you learn about the latest developments in health law. Our lawyers will identify the most important changes and analyze the impact of these changes on our clients.

Find more items tagged as: Health Care and FDA
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel